About the Product

Description


Ofloglee F Tablet containing Ofloxacin and Flavoxate is used for the management of urinary tract infections and associated urinary discomfort. It helps control bacterial infection and relieves bladder spasms.

Ofloxacin works as a fluoroquinolone antibiotic that inhibits bacterial growth, while Flavoxate acts as a urinary tract antispasmodic that reduces pain, urgency, and discomfort.

The tablet is widely prescribed in urology and general medicine practice for urinary tract infections with irritative symptoms, leading to consistent prescription demand.

With increasing prevalence of urinary tract infections and urinary disorders, this product offers strong business potential for retailers and distributors. Its dual therapeutic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the urology segment.

Some patients may experience nausea, dizziness, headache, abdominal discomfort, dry mouth, or altered taste. Rarely, allergic reactions, tendon-related issues, or nervous system disturbances may occur and require medical attention.

Ofloglee F Tablet is indicated for urinary tract infections (UTIs), painful urination, urinary urgency, frequency, and bladder spasms associated with bacterial infections. It helps eliminate bacteria, reduce inflammation, and relieve urinary discomfort.

This medicine should be used under medical supervision. Complete the full prescribed course to avoid antibiotic resistance. Use cautiously in elderly patients or those with kidney disorders or a history of tendon problems.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ofloglee F Tablet in the PCD pharma franchise market?

Ofloglee F Tablet, containing Ofloxacin 200mg and Flavoxate 200mg, has strong demand in the urology and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on urinary tract care portfolios.

Why should medical distributors include Ofloglee F Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for combination therapies used in urinary tract infections (UTIs), painful urination, urinary spasms, and bladder discomfort. The combination of antibiotic and urinary antispasmodic support helps strengthen a comprehensive urology care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Ofloglee F Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ofloglee F Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Ofloglee F Tablet distribution?

Wholesalers and medical agencies benefit from steady urology prescription demand, reliable supply chain support, strong retail movement, and good margins when partnering for Ofloglee F Tablet distribution.

How can I become a distributor or franchise partner for Ofloglee F Tablet?

Medical distributors, stockists, and wholesalers interested in Ofloglee F Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.